| Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis OIOIICI Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B ... N. Engl. J. Med. 376: 221-234. 2017 376 (3), 221-234, 0 | 2033* | |
| Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open … R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ... The Lancet Neurology 17 (5), 405-415, 2018 | 367 | 2018 |
| Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators VW Yong, RK Zabad, S Agrawal, AG DaSilva, LM Metz Journal of the neurological sciences 259 (1-2), 79-84, 2007 | 197 | 2007 |
| The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study RK Zabad, LM Metz, TR Todoruk, Y Zhang, JR Mitchell, M Yeung, ... Multiple Sclerosis Journal 13 (4), 517-526, 2007 | 152 | 2007 |
| The association of depression with disease course in multiple sclerosis RK Zabad, SB Patten, LM Metz Neurology 64 (2), 359-360, 2005 | 96 | 2005 |
| Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial BAC Cree, G Cutter, JS Wolinsky, MS Freedman, G Comi, G Giovannoni, ... The Lancet Neurology 19 (12), 988-997, 2020 | 95 | 2020 |
| Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb RNFSG Giovannoni G, Barbarash O, Casset-Semanaz F, King J, Metz L, Pardo G ... Multiple Sclerosis 15, 219-228, 2009 | 92* | 2009 |
| Sex effects across the lifespan in women with multiple sclerosis KM Krysko, JS Graves, R Dobson, A Altintas, MP Amato, J Bernard, ... Therapeutic advances in neurological disorders 13, 1756286420936166, 2020 | 89 | 2020 |
| CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment Y Cao, A Nylander, S Ramanan, BA Goods, G Ponath, R Zabad, ... Neurology 86 (16), 1553-1556, 2016 | 81 | 2016 |
| Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis JS Perumal, C Caon, S Hreha, R Zabad, A Tselis, R Lisak, O Khan European journal of neurology 15 (7), 677-680, 2008 | 78 | 2008 |
| Deep grey matterblack T2on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis Y Zhang, RK Zabad, X Wei, LM Metz, MD Hill, JR Mitchell Multiple Sclerosis Journal 13 (7), 880-883, 2007 | 69 | 2007 |
| Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis MW Koch, R Zabad, F Giuliani, W Hader Jr, R Lewkonia, L Metz, VW Yong Journal of the neurological sciences 358 (1-2), 131-137, 2015 | 57 | 2015 |
| Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase … RNFSG Giovannoni G, Barbarash O, Casset-Semanaz F, Jaber A, King J, Metz L ... Clinical Therapeutics 29, 1128-45, 2007 | 52 | 2007 |
| Acute transverse myelitis with normal brain MRI: long-term risk of MS J Perumal, R Zabad, C Caon, M MacKenzie, A Tselis, F Bao, Z Latif, I Zak, ... Journal of neurology 255, 89-93, 2008 | 39 | 2008 |
| Two different types of high-frequency physical therapy promote improvements in the balance and mobility of persons with multiple sclerosis BL Davies, DJ Arpin, M Liu, H Reelfs, KG Volkman, K Healey, R Zabad, ... Archives of physical medicine and rehabilitation 97 (12), 2095-2101. e3, 2016 | 34 | 2016 |
| Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis O Khan, R Zabad, C Caon, M Zvartau-Hind, A Tselis, R Lisak Cns Drugs 16, 563-578, 2002 | 34 | 2002 |
| Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures O Taraschenko, R Zabad Epilepsy & Behavior Reports 12, 100338, 2019 | 32 | 2019 |
| Altered sensorimotor cortical oscillations in individuals with multiple sclerosis suggests a faulty internal model DJ Arpin, E Heinrichs‐Graham, JE Gehringer, R Zabad, TW Wilson, ... Human brain mapping 38 (8), 4009-4018, 2017 | 29 | 2017 |
| Neurorehabilitation strategies focusing on ankle control improve mobility and posture in persons with multiple sclerosis BL Davies, DJ Arpin, KG Volkman, B Corr, H Reelfs, RT Harbourne, ... Journal of Neurologic Physical Therapy 39 (4), 225-232, 2015 | 26 | 2015 |
| Pattern recognition of the multiple sclerosis syndrome RK Zabad, R Stewart, KM Healey Brain Sciences 7 (10), 138, 2017 | 25 | 2017 |
